U.S. Markets closed

BridgeBio Pharma: 3Q Earnings Snapshot

PALO ALTO, Calif. (AP) _ BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $60 million in its third quarter.

On a per-share basis, the Palo Alto, California-based company said it had a loss of 51 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 55 cents per share.

The rare disease drug developer posted revenue of $26.7 million in the period.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BBIO at https://www.zacks.com/ap/BBIO